RESPONSIBLE RETURN OF RESULTS
DIFFERENTIATE THROUGH POST-RESULT ENGAGEMENT

Testing quality and turnaround time are commoditizing. The next competitive dimension is what you offer after the result. My Gene Counsel gives your lab a post-result engagement capability that no commodity workflow provides — plain-language Living Lab Reports® that explain the result, update as science evolves, and notify patients and providers when clinical meaning changes. Available white-labeled under your brand.

IMPROVES ENGAGEMENT
RECLASSIFICATION AT SCALE

Every lab that returns VUS results has a reclassification obligation — most manage it manually. Genetic Alerts automates it. When a VUS on your panel is reclassified, the platform identifies affected patients in your network and delivers updated reports automatically. At laboratory volume, this is both a clinical quality tool and a significant liability management asset.

LABS & PRECISION MEDICINE PARTNERS

Your result is the beginning of the clinical relationship.

We’re what happens next.

My Gene Counsel extends your relationship beyond the result — and makes it easier to build that relationship from the start. My Gene Screen gives your ordering clinicians a pre-test eligibility tool so orders arrive clinically appropriate and payer-ready. Living Lab Reports® make every result immediately actionable for patients and providers. And Genetic Alerts automate your VUS reclassification obligations so nothing falls through the cracks post-reporting.

The result: your clinicians order more confidently, your patients are better supported after testing, and your lab differentiates by doing something your competitors don’t — staying present through the entire clinical journey, not just the report. All three tools, or any combination, connect directly to your existing reporting workflow.

 

The idea to create a scalable, digital genetic counseling tool that would serve medical practices of all sizes was innovative and has arrived when it is needed most.

VINCENT T. DEVITA, JR., MD

Previous Director NCI, ACS, and Yale Cancer Center